Non-steroidal anti-inflammatory drug-associated nephrotoxicity in Bartter syndrome

A D Schachter1, G S Arbus, R J Alexander

  • 1Department of Pediatrics, The Hospital for Sick Children and University of Toronto, Ontario, Canada.

Insights

Non-steroidal anti-inflammatory drugs (NSAID) can cause reversible or irreversible kidney problems in patients with Bartter syndrome. This study highlights the importance of considering NSAID use when evaluating renal dysfunction in these patients.

Area of Science:

  • Nephrology
  • Pharmacology
  • Genetics

Background:

  • Bartter syndrome is a rare genetic kidney disorder affecting salt reabsorption.
  • Long-term management often involves addressing electrolyte imbalances and potential complications.
  • Non-steroidal anti-inflammatory drugs (NSAID) are sometimes used, but their renal effects in this population are not fully understood.

Purpose of the Study:

  • To investigate the impact of non-steroidal anti-inflammatory drugs (NSAID) on renal function in patients with Bartter syndrome.
  • To determine if NSAID-induced renal dysfunction is reversible in Bartter syndrome patients.

Main Methods:

  • Longitudinal follow-up of four patients diagnosed with Bartter syndrome.
  • Monitoring of renal function in relation to non-steroidal anti-inflammatory drug (NSAID) therapy.
  • Assessment of renal function changes after NSAID withdrawal.

Main Results:

  • All four patients received non-steroidal anti-inflammatory drugs (NSAID).
  • Temporal association observed between NSAID use and varying degrees of renal dysfunction.
  • Two patients showed resolved renal dysfunction after NSAID discontinuation.
  • Two patients experienced persistent renal dysfunction despite NSAID withdrawal.

Conclusions:

  • Non-steroidal anti-inflammatory drugs (NSAID) represent a significant risk factor for renal dysfunction in Bartter syndrome.
  • NSAID-induced renal impairment can be either reversible or irreversible in these patients.
  • Clinicians should carefully consider NSAID use as a potential cause of renal dysfunction in Bartter syndrome.

Related Concept Videos

Antihypertensive Drugs: Potassium-Sparing Diuretics01:28

Antihypertensive Drugs: Potassium-Sparing Diuretics

Liddle syndrome is a genetically inherited form of hypertension characterized by the overactivity of epithelial sodium channels in the nephron, the functional unit of the kidney. This heightened activity leads to increased sodium reabsorption and excessive excretion of potassium. To counteract this, potassium-sparing diuretics such as amiloride are used. They function by blocking these sodium channels, thereby reducing the influx of sodium into the epithelial cells and minimizing the loss of...
Antihypertensive Drugs: Direct Renin Inhibitors01:25

Antihypertensive Drugs: Direct Renin Inhibitors

The renin-angiotensin-aldosterone system (RAAS) is an intricate physiological pathway involving numerous enzymes and hormones, including renin, angiotensin-converting enzyme (ACE), angiotensin I and II, and aldosterone. Imbalances within this system increase the production of angiotensin II and aldosterone. Increased angiotensin II levels promote vasoconstriction and blood pressure elevation. Concurrently, higher aldosterone levels stimulate sodium and water reabsorption in the kidneys,...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF01:24

Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF

Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
Acute Kidney Injury II: Pathophysiology01:29

Acute Kidney Injury II: Pathophysiology

Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
Acute Kidney Injury IV: Diagnostic Studies and Prevention01:30

Acute Kidney Injury IV: Diagnostic Studies and Prevention

Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...